Skip to main content

Access to Breakthroughs

Poll: Respondents More Likely to Vote for U.S. Congressional Candidates who Support Requiring Medicare to Broaden Patient Access to TAVR

Poll: Respondents More Likely to Vote for U.S. Congressional Candidates who Support Requiring Medicare to Broaden Patient Access to TAVR

May 20, 2026

Alliance Convenes Experts in Alzheimer’s at 18th Annual FDA/ACT-AD Allies Meeting

Alliance Convenes Experts in Alzheimer’s at 18th Annual FDA/ACT-AD Allies Meeting

January 21, 2026

Alliance Letter: Proposed Tariffs Could Compromise Access to Needed Medical Technologies

October 17, 2025

Alliance to HHS: Eliminate CED, Long-Stay Antipsychotic Medication Quality Measure

Alliance to HHS: Eliminate CED, Long-Stay Antipsychotic Medication Quality Measure

July 14, 2025

More than 45 Organizations Submit Public Comment Letter to VRBAC and the FDA on COVID-19 Vaccines

More than 45 Organizations Submit Public Comment Letter to VRBAC and the FDA on COVID-19 Vaccines

May 22, 2025

Briefing Outlines How Federal Budget Cuts Will Harm Older Adults

Briefing Outlines How Federal Budget Cuts Will Harm Older Adults

May 22, 2025

Statement: PERA Act will Help Discoveries Move Beyond the Lab, Reach Patients

May 1, 2025

White Paper: Strong Intellectual Property Protections Improve Patient Access to Lifesaving Medicines

White Paper: Strong Intellectual Property Protections Improve Patient Access to Lifesaving Medicines

April 30, 2025

Access to Treatments, Preserving Medicaid, and Keeping Americans Healthy are Main Themes at Health Next Summit

Access to Treatments, Preserving Medicaid, and Keeping Americans Healthy are Main Themes at Health Next Summit

March 27, 2025

New Poll: Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer’s Medications the Same Way They Do for All Other Diseases

New Poll: Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer’s Medications the Same Way They Do for All Other Diseases

October 10, 2024

UPDATE – Part D Plans Respond to Sign-On Letter from 29 Organizations Opposing Access Barriers to CDC-Recommended Vaccines for Older Adults

UPDATE – Part D Plans Respond to Sign-On Letter from 29 Organizations Opposing Access Barriers to CDC-Recommended Vaccines for Older Adults

August 5, 2024

Alliance to FDA About Potential Donanemab Approval: ‘It’s Critical That We Get This Right’

Alliance to FDA About Potential Donanemab Approval: ‘It’s Critical That We Get This Right’

June 10, 2024

Alliance’s ACT-AD, Leading Organizations Share Feedback on Alzheimer’s Research

Alliance’s ACT-AD, Leading Organizations Share Feedback on Alzheimer’s Research

June 10, 2024

Alliance Statement to MEDCAC on Devices for Self-management of Type 1 and Insulin-Dependent Type 2 Diabetes

Alliance Statement to MEDCAC on Devices for Self-management of Type 1 and Insulin-Dependent Type 2 Diabetes

May 21, 2024

Non-Diabetes Advocacy Groups: Let Clinicians Help Medicare Beneficiaries to Determine Interventions, Not Barriers

Non-Diabetes Advocacy Groups: Let Clinicians Help Medicare Beneficiaries to Determine Interventions, Not Barriers

May 21, 2024

Alliance, 28 Others Oppose Payer Access Barrier to CDC-Recommended Vaccines for Older Adults

Alliance, 28 Others Oppose Payer Access Barrier to CDC-Recommended Vaccines for Older Adults

May 17, 2024